Rep. Stephen Lynch Investigates Elon Musk's Alleged Drug Use During 2024 Campaign and White House Tenure
The House Oversight and Government Reform Committee's acting top Democrat has requested information from President Trump regarding Elon Musk's alleged drug use during the 2024 presidential campaign and his time as a top adviser in the White House. Rep. Stephen Lynch is investigating Musk's supposed drug consumption and is seeking details on what the president and other administration officials knew about it. Musk recently concluded his tenure as a special government employee overseeing government efficiency efforts but remains a friend and adviser to Mr. Trump.
Lynch's inquiry follows a New York Times report alleging Musk's frequent use of ketamine, Ecstasy, and psychedelic mushrooms during the 2024 campaign. Musk responded on social media, acknowledging past use of prescription ketamine for mental health but denied the Times' claims. The Times defended its reporting, stating Musk declined to provide evidence or rebut the allegations before publication. Musk dismissed questions about his drug use during an event with Mr. Trump, criticizing the Times' credibility.
Musk previously disclosed his occasional ketamine use in an interview, emphasizing the importance of moderation due to its impact on productivity. Concerns about Musk's drug use were raised by executives and board members at his companies, as reported by the Wall Street Journal. Musk's possession of a top secret security clearance raised questions about drug testing procedures during the clearance process. Lynch's letter to Mr. Trump seeks clarification on Musk's drug use while working in the White House and any potential influence on his government-related activities.
The investigation aims to determine whether Musk used illegal drugs on the White House premises or in federal buildings and what knowledge the president or his campaign had about Musk's alleged drug use during the 2024 campaign. Musk's role as a special government employee involved assisting in streamlining the federal government's operations, attending Cabinet meetings, and accompanying the president on official trips. The inquiry underscores the importance of transparency regarding Musk's drug use and its potential impact on his government responsibilities.